Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Phase II Pilot Study of the Trillium Full Face Mask

NCT: NCT06932055 · COMPLETED

NCT IDNCT06932055
StatusCOMPLETED
Start Date2025-07-15
Completion2025-08-19
SponsorPhilips Clinical & Medical Affairs Global (INDUSTRY)
First posted
Last updated

Brief Summary

This will be a single-center, open-label randomized crossover design pilot study to evaluate the clinical safety, clinical performance, and clinical benefit of the Trillium full face mask

Frequently Asked Questions

What is A Phase II Pilot Study of the Trillium Full Face Mask?

A Phase II Pilot Study of the Trillium Full Face Mask is a clinical trial registered under NCT06932055. Current status: COMPLETED.

What is the status of NCT06932055?

The current status of NCT06932055 (A Phase II Pilot Study of the Trillium Full Face Mask) is: COMPLETED.

When did A Phase II Pilot Study of the Trillium Full Face Mask start?

A Phase II Pilot Study of the Trillium Full Face Mask started on 2025-07-15.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑